Biotest AG provided earnings guidance for the year 2021. For financial year 2021, the company expects revenue figure in a middle single-digit percentage range in 2021. And The company will reduce EBIT, which was at the end of September minus EUR 11.2 million, and it will get into the range of minus EUR 5 million to minus EUR 10 million.